I have worked in the NHS for 34 years, specialising in cardiac imaging, particularly echo, TOE and CTCA. I use my skills and experience daily within my busy clinical work as a cardiologist in a large district general hospital. I am a member of regional weekly MDMs for valve disease, which facilitates effective communication with our surgical and interventional teams. In 2022 I set up and chair the regional endocarditis MDM and I also lead the Adult congenital heart disease and cardio oncology service.
Dr Hussain was appointed as a Consultant Interventional Cardiologist at Glenfield Hospital, Leicester in 2018 after completing her registrar training at Papworth Hospital in Cambridge. This was followed by an International fellowship when she was awarded the prestigious BCIS Interventional Fellowship at Toronto General Hospital, Canada. She is an Honorary Senior Lecturer at the University of Leicester having undertaken a dedicated period of research culminating in a PhD awarded from King’s College, University of London. This has resulted in a number of peer-reviewed publications including as a major author on the MR-INFORM study, published in the New England Journal of Medicine (2019). Dr Hussain was selected for leadership training as part of inaugural cohort of the BCS Emerging Leaders Course and is an elected member of the British Cardiovascular Society (BCS) Education committee and a course director for the BCS Early Consultant Careers Course. In addition, she is active and passionate about addressing the gender imbalance in Cardiology and is a leading member of the BCS and BCIS Women in Cardiology working groups and has developed many initiatives to increase representation.
Brian is a Clinical Senior Lecturer at the National Heart and Lung Institute, Imperial College and Honorary Consultant Cardiologist at Royal Brompton and Harefield Hospitals, Guys’ and St Thomas’ NHS Trust and BHF Intermediate Fellow,. His research and clinical interests focus on the management of patients with cardiomyopathy and the use of cardiovascular magnetic resonance to improve treatment stratification. He aims to develop patient-centred, precision treatment approaches using targeted therapies and adaptable strategies guided by in-depth characterisation of the underlying dynamic disease substrate. He is particularly interested in the concepts of myocardial recovery and remission and methods to distinguish between the two.
Dr Elyas is a consultant stroke physician at the Royal Devon University Healthcare NHS Foundation Trust and honorary senior clinical lecturer at the University Of Exeter Medical School. He is the southwest peninsula clinical research network specialty lead for stroke. He has a special interest in risk prediction in stroke and TIA, Transcranial Doppler, cerebral small vessel disease and advanced imaging in stroke and neurovascular diseases. He completed his PhD research at the University of Exeter and published and presented his research in peer reviewed journals, national and international meetings and conferences. He is a member of the British and Irish Association of Stroke Physicians, European Stroke organization and World Stroke Congress.
Dr Sankaranarayanan (MBBS FRCP FESC FHFA PhD ) is a Consultant Cardiologist and Heart Failure Lead at Aintree University Hospital (Liverpool University Hospitals NHS Trust) as well as the Heart Failure Pathway Improvement Lead in the Cheshire and Merseyside ICB.
Dr Sankaranarayanan graduated from Bangalore Medical College and Research Institute, India in 2002 and moved to the UK where underwent his residency and cardiology fellowship training at Manchester (Wythenshawe Hospital, Manchester Royal Infirmary). He also undertook a British Heart Foundation funded PhD research project into heart failure and arrhythmogenesis.
He has won several awards including National Awards for innovations such as creating the Roy Award from HF Patient Charity Pumping Marvellous, creating UK’s 1stNHS heart failure Mobile APP for patients, HSJ and BMJ Awards nomination for creating the world’s 1st multi-speciality virtual heart failure MDT, leading the novel Aintree ambulatory acute heart failure unit and for patient education. He was chosen by the British Cardiac Society as one of the top 15 emerging leaders in 2018 and has been elected to the British Cardiac Society Digital Committee, British Society for HF (Digital and Medica Committee). He was awarded a £240,000 NHSX grant and launched the country's 1st acute heart failure virtual ward earlier this year. He is part of several expert panels (NHS England HF PIFU, NHS England GIRFT Committee, BSH Board)
He also has an active research role as NIHR Advanced Research Scholar and as Honorary Senior Clinical Lecturer at the University of Liverpool. He has acquired in >1million£ of research grants and is the PI of several multicentre research trials. He has >50 peer reviewed publications and has several ongoing international research collaborations.
Dr Lockie attended University College School, before training at Edinburgh University. He undertook an intercalated degree, gaining first class honours. After graduation, he worked in Edinburgh before moving to London for his specialist cardiology training.
With an interest in ischaemic heart disease, he undertook a PhD at King’s College, London, winning the Young Investigator prize, as well as presenting and publishing his work around the world.
He spent a year at the Academic Medical Centre in Amsterdam undertaking further training in advanced percutaneous coronary interventions (PCI). He now works as a consultant interventional cardiologist at the Royal Free London.
Dr Lockie specialises in complex PCI, intravascular imaging and coronary physiology, and has an ongoing interest in research being the principle site investigator for several large studies.
He was appointed as clinical service lead for cardiology across all Royal Free London sites and associate professor of cardiology, Univeristy College London. He has also been elected as a fellow of the European Society of Cardiology.
Dr Rebecca Dobson is a Consultant Cardiologist at the Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool Heart & Chest Hospital, in Liverpool, UK. She has a special interest in imaging and cardio-oncology.
Dr Dobson's research interests include cardio-oncology, cardiac imaging and advanced echocardiography, including chemotherapy-induced left ventricular systolic dysfunction, cardiac disease in cancer patients, carcinoid heart disease and heart valve disease.
Dr Dobson is a member of the British Cardiovascular Society, the British Cardio-Oncology Society, the British Society of Echocardiography and the Royal College of Physicians.
Dr Rebecca Dobson is Section Editor of European Cardiology Review.